JAMES SULLIVAN: Open Payments
NPI 1588613020 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,950 in 131 payments from 29 companies in 2025. Trend: 2023 $2,465 · 2024 $2,801 · 2025 $8,950
Speaker / faculty: $5,250Food & beverage: $2,916Travel & lodging: $784
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $3,618 |
| Indivior Inc. | 10 | $3,192 |
| Novo Nordisk Inc | 18 | $315 |
| AstraZeneca Pharmaceuticals LP | 12 | $264 |
| Otsuka America Pharmaceutical, Inc. | 8 | $177 |
| Braeburn Inc. | 6 | $173 |
| PFIZER INC. | 9 | $151 |
| Lilly USA, LLC | 6 | $127 |
| GlaxoSmithKline, LLC. | 4 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $101 |
Products named: REPATHA, SUBLOCADE, REXULTI, BRIXADI, AIRSUPRA, OTEZLA, Ozempic, Rybelsus.
Industry payments across AL — which companies pay providers there.
